|Articles|February 9, 2023
uMotif, ActiGraph Improve Patient's Wearable Experience
Alliance helps patients manage ePRO and wearables in one place.
Advertisement
eCOA/ePRO solutions provide uMotif has joined ActiGraph’s Accelerant™ Partner Program, to combine their solutions. ActiGraph, a provider of wearable remote monitoring technology, and the uMotif solution will allow sponsors and CROs to engage patients and provide a design-led approach to capture both subjective ePRO and objective device data through a single experience.
Read more about the
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
2
Rethinking Operational Models to Reduce Site Burden in 2026
3
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
4
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
5